XS Innovations
Eindhoven, Netherlands· Est. 2010
In 2020, ~3.8 million people worldwide suffered from end-stage kidney disease (ESKD)—a condition that requires life-saving treatment to replace lost kidney function and prevent fatal toxin buildup. Due to a severe shortage of kidney donors, dialysis remains the only option for nearly 80% of ESKD patients.
Private Company
Funding information not available
About
In 2020, ~3.8 million people worldwide suffered from end-stage kidney disease (ESKD)—a condition that requires life-saving treatment to replace lost kidney function and prevent fatal toxin buildup. Due to a severe shortage of kidney donors, dialysis remains the only option for nearly 80% of ESKD patients.
Medical DevicesDrug Delivery